Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

Scemblix is indicated for the treatment of adult patients with: newly diagnosed or c-abl tyrosine kinase inhibitor-pretreated Philadelphia chromosome-positive chronic myeloid leukaemia (Ph+ CML) in chronic phase (CP) (see Pharmacology: Pharmacodynamics: Clinical efficacy under Actions); Ph+ CML-CP harbouring a T315I mutation.

Scemblix Indications/Uses

Manufacturer:

Novartis

Distributor:

Zuellig